These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules. Harris DP, Vordermeier HM, Arya A, Moreno C, Ivanyi J. Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029 [Abstract] [Full Text] [Related]
8. Fine specificity of T cell recognition of the same peptide in association with different I-A molecules. Brett SJ, Cease KB, Ouyang CS, Berzofsky JA. J Immunol; 1989 Aug 01; 143(3):771-9. PubMed ID: 2473109 [Abstract] [Full Text] [Related]
9. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue. Kim BS, Bahk YY, Kang HK, Yauch RL, Kang JA, Park MJ, Ponzio NM. J Immunol; 1999 Jun 15; 162(12):7049-57. PubMed ID: 10358147 [Abstract] [Full Text] [Related]
10. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides. Lakey EK, Casten LA, Anderson MS, Smolenski LA, Smith JA, Margoliash E, Pierce SK. Eur J Immunol; 1987 Nov 15; 17(11):1605-9. PubMed ID: 3500065 [Abstract] [Full Text] [Related]
11. Studies on the clonality of the response to an epitope of a protein antigen. Randomness of activation of epitope-recognizing clones and the development of clonal dominance. Benjamini E, Andria ML, Estin CD, Norton FL, Leung CY. J Immunol; 1988 Jul 01; 141(1):55-63. PubMed ID: 2454264 [Abstract] [Full Text] [Related]
12. Functional heterogeneity of memory B lymphocytes: in vivo analysis of TD-primed B cells responsive to secondary stimulation with TD and TI antigens. Rennick DM, Morrow PR, Benjamini E. J Immunol; 1983 Aug 01; 131(2):561-6. PubMed ID: 6190934 [Abstract] [Full Text] [Related]
13. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. Milich DR, Jones JE, McLachlan A, Houghten R, Thornton GB, Hughes JL. J Immunol; 1989 Nov 15; 143(10):3148-56. PubMed ID: 2478619 [Abstract] [Full Text] [Related]
15. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ, Oshima M, Deitiker P. Crit Rev Immunol; 2001 Nov 15; 21(1-3):1-27. PubMed ID: 11642597 [Abstract] [Full Text] [Related]
16. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein. Rzepczyk CM, Csurhes PA, Saul AJ, Jones GL, Dyer S, Chee D, Goss N, Irving DO. J Immunol; 1992 Feb 15; 148(4):1197-204. PubMed ID: 1371134 [Abstract] [Full Text] [Related]